Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Immunoglobulin prophylaxis against cytomegalovirus infection in patients at high risk of infection following allogeneic hematopoietic cell transplantation.
Ichihara H, Nakamae H, Hirose A, Nakane T, Koh H, Hayashi Y, Nishimoto M, Nakamae M, Yoshida M, Bingo M, Okamura H, Aimoto M, Manabe M, Hagihara K, Terada Y, Nakao Y, Hino M.
Transplant Proc. 2011 Dec;43(10):3927-32.
Related citations
What is the true significance of donor-related cytomegalovirus transmission in the setting of facial composite tissue allotransplantation?
Gordon CR, Abouhassan W, Avery RK.
Transplant Proc. 2011 Nov;43(9):3516-20.
Significance of cytomegalovirus prophylaxis strategies and development of cancer in kidney transplant recipients.
Osorio JC, Medina RD, Patiño N, Ricaurte L, Moreno L, Lozano E.
Transplant Proc. 2011 Nov;43(9):3380-2.
Insidious course of cytomegalovirus infection in hand transplant recipient: case report, diagnostics, and treatment.
Chelmoński A, Jabłecki J, Szajerka T.
Transplant Proc. 2011 Sep;43(7):2827-30.
Monitoring of cytomegalovirus-specific CD8+ T-cell response with major histocompatibility complex pentamers in kidney transplant recipients.
Lee S, Park JB, Kim EY, Joo SY, Shin EC, Kwon CH, Joh JW, Kim SJ.
Transplant Proc. 2011 Sep;43(7):2636-40.
The influence of cytomegalovirus infections on patient and renal graft outcome: a 3-year, multicenter, observational study (Post-ECTAZ Study).
Abou-Ayache R, Büchler M, Le Pogamp P, Westeel PF, Le Meur Y, Etienne I, Hurault de Ligny B, Toupance O, Caillard S, Sinnasse-Raymond G, Touchard G.
Transplant Proc. 2011 Sep;43(7):2630-5.
Clinical usefulness of plasma quantitative polymerase chain reaction assay: diagnosis of cytomegalovirus infection in kidney transplant recipients.
Rhee JY, Peck KR, Lee NY, Song JH.
Transplant Proc. 2011 Sep;43(7):2624-9.
Influence of cytomegalovirus disease in outcome of solid organ transplant patients.
Linares L, Sanclemente G, Cervera C, Hoyo I, Cofán F, Ricart MJ, Pérez-Villa F, Navasa M, Marcos MA, Antón A, Pumarola T, Moreno A.
Transplant Proc. 2011 Jul-Aug;43(6):2145-8.
Cytomegalovirus infection in mesenchymal stem cells and their activation could be enhanced by nuclear factor-κB inhibitor pyrrolidinedithiocarbamate in vitro.
Wei G, Lin M, Cai Z, Huang H.
Transplant Proc. 2011 Jun;43(5):1944-9.
Prophylaxis of cytomegalovirus disease in mismatched patients after heart transplantation using combined antiviral and immunoglobulin therapy.
Czer LS, Ruzza A, Vespignani R, Rafiei M, Pixton JR, Awad M, De Robertis M, Wong AV, Trento A.
Transplant Proc. 2011 Jun;43(5):1887-92.
Cytomegalovirus genotypes gB1 and gH1 are the most predominant genotypes among renal transplant recipients in Kuwait.
Madi N, Al-Nakib W, Pacsa A, Saeed T.
Transplant Proc. 2011 Jun;43(5):1634-7.
Monitoring and detection of cytomegalovirus in liver transplant recipients.
Milan A, Sampaio AM, Guardia AC, Pavan CR, Andrade PD, Bonon SH, Costa SC, Ataíde E, Boin IF, Stucchi RS.
Transplant Proc. 2011 May;43(4):1360-1.
Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in adult liver transplant recipients: diagnosis based on antigenemia.
Sampaio AM, Thomasini RL, Guardia AC, Stucchi RS, Rossi CL, Costa SC, Boin IF.
Transplant Proc. 2011 May;43(4):1357-9.
Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
Varga M, Görög D, Kári D, Környei E, Kis É, Túryné HJ, Jankovics I, Péter A, Toronyi É, Sárváry E, Fazakas J, Reusz G.
Transplant Proc. 2011 May;43(4):1233-5.
Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
Costa C, Astegiano S, Terlizzi ME, Sidoti F, Curtoni A, Solidoro P, Baldi S, Bergallo M, Cavallo R.
Transplant Proc. 2011 May;43(4):1159-61.
Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation.
Snydman DR, Limaye AP, Potena L, Zamora MR.
Transplant Proc. 2011 Apr;43(3 Suppl):S1-S17. Review.
Pediatric liver transplantation for inherited metabolic liver disease: a single-center experience.
Rosencrantz R, Cimsit B, Seashore M, Arvelakis A, Kulkarni S, Ghiroli M, Emre S.
Transplant Proc. 2011 Apr;43(3):896-900.
Lack of cytomegalovirus and polyomavirus coexistence in Iranian kidney transplant recipients.
Nasiri S, Ahmadi SF, Lessan-Pezeshki M, Seyfi S, Alatab S.
Transplant Proc. 2011 Mar;43(2):536-9.
Anemia after kidney transplantation in adult recipients: prevalence and risk factors.
Einollahi B, Lessan-Pezeshki M, Rostami Z, Kalantar E, Afshar R, Beiraghdar F.
Transplant Proc. 2011 Mar;43(2):578-80.
Universal prophylaxis with gancyclovir preparation is not necessary in our kidney allograft recipients.
Tayebi-Khosroshahi H, Makhdami N, Heris HK, Habibzadeh A, Zadimani A, Badrogli N.
Transplant Proc. 2011 Mar;43(2):547-50.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on